erastin - Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Columbia University, Prolexys
Galectin-13 reduces membrane localization of SLC7A11 for ferroptosis propagation. (PubMed, Nat Chem Biol) - Apr 18, 2025 - "A synthetic Galectin-13 mimetic peptide was shown to strongly enhance the sensitivity of tumors to the imidazole ketone erastin, radiotherapy and immunotherapy by boosting ferroptosis. In particular, cancer stem cells were vulnerable to the combination of Galectin-13 mimetic peptide and ferroptosis inducers. Our study provides new insights into ferroptosis propagation and highlights novel strategies for targeting ferroptosis to treat tumors." 
IO biomarker • Journal • Oncology • LGALS1 • PRKCB • SLC7A11
http://www.ncbi.nlm.nih.gov/pubmed/40246981
 
Bing-Xin Hu; Gong-Kan Feng; Hai-Liang Zhang; Hui-Qi Shen; Li-Chao Li; Rong Deng; Shan Liu; Xiao-Feng Zhu; Yi-Qing Guo; Yu-Hong Chen; Zhi-Ling Li; Zhi-Peng Ye
 
Apr 18, 2025
 
Prev Next